Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Gains from Investment Securities (2016 - 2025)

PAVmed has reported Gains from Investment Securities over the past 6 years, most recently at $16878.0 for Q4 2025.

  • For Q4 2025, Gains from Investment Securities rose 5.49% year-over-year to $16878.0; the TTM value through Dec 2025 reached $16878.0, changed N/A, while the annual FY2025 figure was $16878.0, 52.47% down from the prior year.
  • Gains from Investment Securities for Q4 2025 was $16878.0 at PAVmed, down from $61146.0 in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $8.6 billion in Q3 2021 and troughed at $1650.0 in Q2 2021.
  • A 5-year average of $433.9 million and a median of $462077.0 in 2022 define the central range for Gains from Investment Securities.
  • On a YoY basis, Gains from Investment Securities climbed as much as 30254.79% in 2022 and fell as far as 99.96% in 2022.
  • Year by year, Gains from Investment Securities stood at $1.4 million in 2021, then plummeted by 98.94% to $15000.0 in 2022, then plummeted by 73.33% to $4000.0 in 2023, then skyrocketed by 300.0% to $16000.0 in 2024, then rose by 5.49% to $16878.0 in 2025.
  • Business Quant data shows Gains from Investment Securities for PAVM at $16878.0 in Q4 2025, $61146.0 in Q3 2025, and $2.5 million in Q2 2025.